Approved for 1 INDICATIONS AND USAGE SEEBRI ® NEOHALER ® is indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). SEEBRI NEOHALER is an anticholinergic indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD). ( 1 ). 12.1 Mechanism of…
Loading full data from Know Your Drugs Institute…